Research Fields

Mohammad Ramezani (Pharm.D., Ph.D.),

Distinguished Professor,

 Mohammad Ramezani received his Pharma.D. degree from School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran in 1988. He granted a scholarship from the Ministry of Health and Medical Education of Iran to continue his education toward a PhD degree at the Department of Chemistry, Dalhousie University, Canada. After graduation in 1996, he continued his career as an Assistant Professor at the Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences. He was then promoted to position of Associate and full Professor in 2000 and 2004, respectively. Recently, he was promoted to the position of Distinguished Professor. The main focus of Dr. Ramezani’s research is to develop functional nanomaterials for targeted gene and drug delivery purposes. He has published over 360 research papers in highly cited journals such as Advanced Functional Materials, Biomaterials, Journal of Controlled Release, Nanomedicine and International Journal of Pharmaceutics. He also has contributed to several book chapters in the field of Nanomedicine. He is also the Editor-in-Chief of the Nanomedicine Journal, an ESCI Indexed journal, published by the Nanotechnology Research Center, Mashhad University of Medical Sciences. Dr. Ramezani has won the National Razi prize for best investigator twice in 2009 and 2018. He is among 1% highly cited scientists since 2018.

Fatemeh Kalalinia (Pharm.D., Ph.D.),

Associate Professor,

 I am broadly interested in stem cell research and tissue engineering. In particular, my future research plans are aimed towards investigating the new materials that induce osteogenesis, chondrogenesis and neurogenesis. Also, my future research interests are shaped by designing and evaluating the new scaffolds with 3D printing, electrospinning, and freeze drying methods. My research agenda focuses on the question of how to use stem cells for the treatment of bone fractures, cartilage problems, skin diseases, neural system disease and cancers. In the past, we could successfully design some scaffolds for bone defects in in vitro, in vivo and clinical studies. Also, we use electrospinning for developing new drug delivery systems. On the other hand, some of my past researches were focused on investigating the mechanism of multi drug resistance in cancer and evaluating the hypotheses considered in traditional Iranian medicine.

Seyed Mohammad Taghdisi (Pharm.D., Ph.D.),

Associate Professor,

 Seyed Mohammad Taghdisi received his Pharm.D. degree in 2006 from school of Pharmacy, Mazandaran University of Medical Sciences and his Ph.D. in 2011 from the Department of Pharmaceutical Biotechnology, Mashhad University of Medical Sciences, Iran. He is currently Associate Professor at Mashhad University of Medical Sciences. He is interested in aptamer design (SELEX), aptamer-based delivery systems for targeted delivery of therapeutic agents (chemotherapeutic agents, nucleic acid therapeutics and CRISPR) and aptasensors (optical and electrochemical methods). He has authored over 155 research papers and several book chapters. He is among 1% highly cited scientists since 2020.

Mona Alibolandi (M.Sc., Ph.D.),

Assistant Professor,

 Mona Alibolandi received MSc. degree of Microbial Biotechnology in 2008 from Science and Research University of Tehran. Her MSc thesis was about engineering and production of recombinant Human Growth Factor 2. She worked 3 years in Biotechnology Department of Pasteur Institute of Iran as a Research Associate. She received her Ph.D. degree in 2016 form Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Iran in the field of Medical Biotechnology. Her PhD thesis was awarded as the best thesis by the Ministry of Health and Medical Education of Iran, 2015. She is currently Assistant Professor at Mashhad University of Medical Sciences. She is interested in synthesis of hybrid materials and designing targeted drug/gene delivery systems (polymersomes, peptosomes, micelles, self-assembled structures and inorganic NPs). She has authored over 117 research papers and several book chapters. She is among 1% highly cited scientists since 2020.